Platinum Priority – EditorialReferring to the article published on pp. 18–23 of this issueLymph node dissection is not obsolete in clinically node-negative Renal Cell Carcinoma patients
Section snippets
Conflicts of interest
The author has nothing to disclose.
References (8)
- et al.
Lymph node dissection at the time of radical nephrectomy for high-risk clear cell renal cell carcinoma: indications and recommendations for surgical templates
Eur Urol
(2011) - et al.
Enlargement of regional lymph nodes in renal cell carcinoma is often not due to metastases
J Urol
(1990) - et al.
Reassessing the current TNM lymph node staging for renal cell carcinoma
Eur Urol
(2006) - et al.
Lymphadenectomy combined with radical nephrectomy: to do or not to do?
Eur Urol
(2009)
Cited by (14)
Is lymph node dissection necessary for staging while undergoing nephrectomy in patients with renal cell carcinoma?
2021, Current Problems in CancerCitation Excerpt :Unfortunately, the available technology is incapable of accurately identifying small LN metastases. It is not possible to view a normal-sized LN with micro metastases that will benefit from LND with current technology.12,13 Therefore, the absence of suspicion of LN metastasis from current imaging techniques should not convince the surgeon not to perform LND.13
Lymph node dissection in renal cell carcinoma
2011, European UrologyCitation Excerpt :In conclusion, the available technology is capable of accurately identifying only large lymph node metastases. At present, patients with (micro)metastases in normal-sized nodes who might benefit from LND [27] cannot be visualized by any of the above-mentioned techniques [4]. Therefore, when using the available imaging technology, the absence of any evident lymph node metastasis should not preclude the performance of a regional LND.
Lymphadenectomy in Urologic Oncology: Pathologic Considerations
2011, Urologic Clinics of North AmericaCitation Excerpt :Crispen and colleagues reported similar figures. However, others have claimed that if the low morbidity and benefit to staging and possible treatment preclude the value of frozen section and in patients at risk, LAD should proceed.18 Communication between the urologist and pathologist is necessary so that an agreed procedure at their particular institution can be conducted until a consensus is reached.
The Current Role of Lymph Node Dissection in Nonmetastatic Localized Renal Cell Carcinoma
2023, Journal of Clinical MedicineContemporary Role of Open Nephron Sparing Surgery
2022, Renal Cancer: Current Status and InnovationsValuation of lymph node dissection in localized high-risk renal cell cancer using X-tile software
2020, International Urology and Nephrology